Aurinia Pharmaceuticals Inc. (AUPH)

11.31
NASDAQ
Prev Close 11.84
Day Low/High 11.15 / 11.60
52 Wk Low/High 8.86 / 33.97
Exchange NASDAQ
Shares Outstanding 141.74B
Market Cap 1.68B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

There Isn't Any Compelling Reason to Jump in Right Now

There Isn't Any Compelling Reason to Jump in Right Now

We still have this issue with headline risk that is going to make it hard to navigate.

A Subscriber Wants to Know If Aurinia Pharmaceuticals' Charts Have Improved

A Subscriber Wants to Know If Aurinia Pharmaceuticals' Charts Have Improved

Prices look like they can bounce further to the upside in the short-run but the longer-term picture is problematic.

This Isn't a Market That Can Be Easily Trusted

This Isn't a Market That Can Be Easily Trusted

Yet there's good relative strength in biotech, growth, cannabis, small-caps, and other sectors that have been the biggest laggards.

Trust the Bounce? I'd Rather Be Late Than Early

Trust the Bounce? I'd Rather Be Late Than Early

There is one key area where I'm more inclined to add right now.

The Most Difficult Market Environment in Many Years

The Most Difficult Market Environment in Many Years

High P/E and high-beta names have had no support regardless of fundamentals.

Options Play of the Week: A Biotech Back in a Buy Zone

Options Play of the Week: A Biotech Back in a Buy Zone

In this market environment, there is nothing wrong with a 'rinse, wash and repeat' trade.

Several Factors Are Impacting the Market Action

Several Factors Are Impacting the Market Action

I remain optimistic about stock picking and trading as we head into Thanksgiving week.

These 5 Stocks Have Exceptional Fundamentals

These 5 Stocks Have Exceptional Fundamentals

I view this market action as quite positive.

I've Used a Strategy of Trade-Offs With 2 Biotech Stocks

I've Used a Strategy of Trade-Offs With 2 Biotech Stocks

I tend to only use this strategy to a great extent when I have a negative or neutral view on the overall market.

I Have 14 Key Stocks on My Shopping List

I Have 14 Key Stocks on My Shopping List

My positions change very fast and I'm actively trading all these names.

10 Good-Looking Small-Cap Stocks as Markets Mildly Correct

10 Good-Looking Small-Cap Stocks as Markets Mildly Correct

The process of closing the gap between large-caps and secondary stocks may be starting today.

Here's How I'd React to a Selloff on Jackson Hole

Here's How I'd React to a Selloff on Jackson Hole

The move on Thursday wasn't as much a surprise as it would seem, but now we must look to what could happen next.

Lethargic Indices Mask a Spark in Smaller Gaming Stocks

Lethargic Indices Mask a Spark in Smaller Gaming Stocks

A number of gambling stocks are up on word that DraftKings plans to buy Golden Nugget Online Gaming.

Aurinia Pharmaceuticals' Charts Are Showing Side Effects

Aurinia Pharmaceuticals' Charts Are Showing Side Effects

Here's what to avoid.

I'm Looking for Some Mild Pullbacks to Create Another Round of Setups

I'm Looking for Some Mild Pullbacks to Create Another Round of Setups

There are plenty of small-caps that have finally bounced and are now consolidating.

The Indices and Broader Markets Need Much More Work to Hit a Good Low

The Indices and Broader Markets Need Much More Work to Hit a Good Low

Much of the action has to do with the disconnect recently between the indices and the vast majority of individual stocks.

The Good News Is That the Overall Price Action Is Positive

The Good News Is That the Overall Price Action Is Positive

We're going to see some random action in front of the weekend.

It's Time for a Bit of Repositioning as Another Earnings Season Approaches

It's Time for a Bit of Repositioning as Another Earnings Season Approaches

The end of the quarter means a new round of quarterly reports is near, so it pays to keep an eye on favorite names.

The Market Turns on News of Delta Variant, Russell Indexing

The Market Turns on News of Delta Variant, Russell Indexing

Technology strengthens, while the Dow Jones industrial average and Russell 2000 lag.

Stock Picking Remains the Name of the Game

Stock Picking Remains the Name of the Game

The tricky part is that sector strength is shifting fast.

It Is a Dull Market, but Here Are Several Names I'm Trading

It Is a Dull Market, but Here Are Several Names I'm Trading

Action like this sometimes leads to a 'don't short a dull market' response.

My Impression Now Is That Market Players Lack Energy

My Impression Now Is That Market Players Lack Energy

I don't want to sound negative as it's a major positive that there isn't aggressive downside follow through.

Focus on the Price Action, and Avoid the Perma-Pessimists

Focus on the Price Action, and Avoid the Perma-Pessimists

Stocks with good charts, good fundamentals, and good stories are attracting buyers.

This Picker's on the Prowl: Here's What I'm Trading

This Picker's on the Prowl: Here's What I'm Trading

I've been very busy making some quick trades.

Keep an Eye on Biotech and Cryptos as the Weekend Approaches

Keep an Eye on Biotech and Cryptos as the Weekend Approaches

There's one name I've added to today.

Long-Suffering Biotech May Be Hitting a Bottom

Long-Suffering Biotech May Be Hitting a Bottom

Here are some biotech and gaming names I am watching as these sectors begin to rotate.

Biotechs Are One of the Few Positives in This Ugly Market

Biotechs Are One of the Few Positives in This Ugly Market

Of 56 recent ARKK buys, only two are trading in positive territory Wednesday.

The Selling Pressure on Many Stocks Is Brutal

The Selling Pressure on Many Stocks Is Brutal

The good news is that this sort of action always eventually leads to great stock picking.